Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1981 2
1983 3
1984 1
1986 3
1987 1
1988 1
1989 3
1990 1
1991 3
1992 1
1994 2
1995 1
1996 1
1997 6
1998 1
1999 1
2000 3
2001 3
2002 2
2003 1
2004 5
2005 8
2006 5
2007 4
2008 10
2009 11
2010 8
2011 12
2012 14
2013 18
2014 18
2015 19
2016 16
2017 7
2018 19
2019 33
2020 43
2021 45
2022 28
2023 34
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

346 results

Results by year

Filters applied: . Clear all
Page 1
Italian Guidelines in diagnosis and treatment of alopecia areata.
Rossi A, Muscianese M, Piraccini BM, Starace M, Carlesimo M, Mandel VD, Alessandrini A, Calvieri S, Caro G, D'arino A, Federico A, Magri F, Pigliacelli F, Amendolagine G, Annunziata MC, Arisi MC, Astorino S, Babino G, Bardazzi F, Barruscotti S, Belloni Fortina A, Borghi A, Bruni F, Caccavale S, Calzavara-Pinton P, Cameli N, Cardone M, Carugno A, Coppola R, Dattola A, De Felici Del Giudice MB, Di Cesare A, Dika E, Di Nunno D, D'ovidio R, Fabbrocini G, Feliciani C, Fulgione E, Galluzzo M, Garcovich S, Garelli V, Guerriero C, Hansel K, La Placa M, Lacarrubba F, Lora V, Marinello E, Megna M, Micali G, Misciali C, Monari P, Monfrecola G, Neri I, Offidani A, Orlando G, Papini M, Patrizi A, Piaserico S, Rivetti N, Simonetti O, Stan TR, Stingeni L, Talamonti M, Tassone F, Villa L, Vincenzi C, Fortuna MC. Rossi A, et al. Among authors: magri f. G Ital Dermatol Venereol. 2019 Dec;154(6):609-623. doi: 10.23736/S0392-0488.19.06458-7. Epub 2019 Sep 26. G Ital Dermatol Venereol. 2019. PMID: 31578836 Free article.
Thyroid Disrupting Effects of Old and New Generation PFAS.
Coperchini F, Croce L, Ricci G, Magri F, Rotondi M, Imbriani M, Chiovato L. Coperchini F, et al. Among authors: magri f. Front Endocrinol (Lausanne). 2021 Jan 19;11:612320. doi: 10.3389/fendo.2020.612320. eCollection 2020. Front Endocrinol (Lausanne). 2021. PMID: 33542707 Free PMC article. Review.
Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study.
Chiriboga CA, Bruno C, Duong T, Fischer D, Mercuri E, Kirschner J, Kostera-Pruszczyk A, Jaber B, Gorni K, Kletzl H, Carruthers I, Martin C, Warren F, Scalco RS, Wagner KR, Muntoni F; JEWELFISH Study Group. Chiriboga CA, et al. Neurol Ther. 2023 Apr;12(2):543-557. doi: 10.1007/s40120-023-00444-1. Epub 2023 Feb 13. Neurol Ther. 2023. PMID: 36780114 Free PMC article.
Sannino-Barduagni-Bottoni Syndrome.
Pranteda G, Magri F, Moliterni E, Pranteda G, Quaglino P. Pranteda G, et al. Among authors: magri f. G Ital Dermatol Venereol. 2019 Dec;154(6):732-734. doi: 10.23736/S0392-0488.18.05969-2. Epub 2018 Oct 3. G Ital Dermatol Venereol. 2019. PMID: 30295441 Review. No abstract available.
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial.
Mercuri E, Muntoni F, Baranello G, Masson R, Boespflug-Tanguy O, Bruno C, Corti S, Daron A, Deconinck N, Servais L, Straub V, Ouyang H, Chand D, Tauscher-Wisniewski S, Mendonca N, Lavrov A; STR1VE-EU study group. Mercuri E, et al. Lancet Neurol. 2021 Oct;20(10):832-841. doi: 10.1016/S1474-4422(21)00251-9. Lancet Neurol. 2021. PMID: 34536405 Clinical Trial.
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial.
Mercuri E, Deconinck N, Mazzone ES, Nascimento A, Oskoui M, Saito K, Vuillerot C, Baranello G, Boespflug-Tanguy O, Goemans N, Kirschner J, Kostera-Pruszczyk A, Servais L, Gerber M, Gorni K, Khwaja O, Kletzl H, Scalco RS, Staunton H, Yeung WY, Martin C, Fontoura P, Day JW; SUNFISH Study Group. Mercuri E, et al. Lancet Neurol. 2022 Jan;21(1):42-52. doi: 10.1016/S1474-4422(21)00367-7. Lancet Neurol. 2022. PMID: 34942136
The multifaceted anti-cancer effects of BRAF-inhibitors.
Croce L, Coperchini F, Magri F, Chiovato L, Rotondi M. Croce L, et al. Among authors: magri f. Oncotarget. 2019 Nov 12;10(61):6623-6640. doi: 10.18632/oncotarget.27304. eCollection 2019 Nov 12. Oncotarget. 2019. PMID: 31762942 Free PMC article. Review.
346 results